Catalyst — Full Portfolio
6 tracked investments · listed companies and verified rows first
Harbinger Health develops early cancer detection technology through its Harbinger HX platform, which embeds developmental biology into biomarker discovery, assay design, and model training to detect faint biological signals of early cancer in real-world samples.
AI & Machine LearningBiotechDigital HealthHealthtech
Co-investorsFlagship Pioneering
Neural Payments provides a white-labeled payments hub for banks and credit unions, unifying payment rails (ACH, RTP, FedNow, debit networks, and digital wallets) through a single integration.
AI & Machine LearningFintechSaaSMason, US
Michael Oppy(Executive Officer, Director)
BoardIsaac Saldana(Director)Ryan Gorney(Director)Martin Walker(Director)Alice Ann Schwartz(Director)
Co-investorsCommerce VenturesCurql Collective, LLCNext Level VenturesPS27 VenturesSixThirty Ventures
Sevaro is a healthcare technology company focused on advancing stroke care through clinical trials, artificial intelligence, medical informatics, and telemedicine solutions.
AI & Machine LearningDigital HealthHealthtechNorth Brunswick, US
Dr. Rajiv Narula(Executive Officer, Director)Krishan Narula(Executive Officer, Director)
BoardKapil Desai(Director)inAnna Haghgooie(Director)Ajay Sharma(Director)
Co-investorsAPA Venture PartnersCatalyst InvestorsBlueCross BlueShield Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


